Hints and tips:
Related Special Reports
...But he ruled out bidding for companies with potential obesity treatments, despite surging sales of weight loss and diabetes drugs sold by Novo Nordisk and Eli Lilly....
...But she said if Novo Nordisk could develop such a treatment, it would be “ideal”....
...The new type of contract has previously only been used to spread the cost of advanced treatments such as gene therapy....
...summer, after presenting the findings in full at the American Diabetes Association annual meeting in June....
...Obesity drugs are derived from type 2 diabetes treatments, and use the same compounds but in varying doses....
...Tirzepatide is already sold under the name Mounjaro as a diabetes treatment in both countries....
...cheaper treatments....
...Healthcare providers in the US wrote more than 9mn prescriptions for Ozempic and similar weight loss and diabetes drugs in the final quarter of 2022, as demand soars for the blockbuster treatments....
...Eli Lilly and Novo Nordisk first received approval for GLP-1-based treatments — for diabetes — in 2005 and 2010 respectively....
...The company’s weight-loss drug Wegovy and diabetes treatment Ozempic powered it to record sales in 2023 and a current market capitalisation of $508bn....
...Critics have also slammed industry leaders Eli Lilly and Biogen for charging excessive prices for treatments for common diseases such as diabetes and Alzheimer’s....
...Scientists are now researching the drug as a possible treatment for alcohol use disorders....
...This week, however, one of the local leaders apologised for misleading investors about obesity treatments. That pushed stocks to the opposite extreme....
...They include Eliquis, a blood thinner produced by Bristol Myers Squibb (BMS) and its partner Pfizer, the diabetes treatment Jardiance sold by Boehringer Ingelheim and Eli Lilly, and Xarelto, another blood...
...The president is facing mounting concerns about his advanced age as he tries to convince voters to give him another four years in the White House....
...But she said the fact that Medicare does cover semaglutide for treatment of diabetes suggests that, after the new data, it could cover the drug for people with cardiac conditions....
...He added that Novo Nordisk’s and Eli Lilly’s blockbuster diabetes and weight loss drugs Ozempic and Mounjaro could be included on the list in 2027 and 2031 respectively....
...The Center for Global Policy Solutions believes robotaxis will cost about $0.75 per mile to run, including insurance and maintenance....
...Prashant Yadav is a senior fellow at the Center for Global Development and affiliate professor at Insead Many groundbreaking innovations in life sciences — from novel treatments and diagnostics to digital...
...But the Center for Strategic and International Studies describes Chinese state support as “uniquely high”, estimating it at $406bn, or 1.73 per cent of GDP, in 2019....
...But without GP data, it is hard to make much headway on conditions like dementia, Parkinson’s, depression or diabetes....
...It was approved by the US Food and Drug Administration last May to treat type-2 diabetes under the brand name Mounjaro, but Lilly aims to tap the fast-growing market for weight loss treatments by getting...
...Indivior is seeking to diversify beyond its existing portfolio of treatments for opioid use disorder and schizophrenia as it considers a secondary listing in the US later this year....
...National Security Council spokesperson John Kirby said Biden would raise concerns about Chinese human rights abuses, including its treatment of Uyghurs in Xinjiang, in his talks with Xi....
...The findings predate the availability of any medical treatments for the condition, so Brayne’s hypothesis is that reducing incidence requires “optimising neurological function” throughout the course of a...
International Edition